A novel antidepressant-like action of drugs possessing GIRK channel blocking action in rats

Yakugaku Zasshi

Volumn 130, Issue 5, 2010, Pages 699-705

  Kawaura, Kazuaki ^a   Honda, Sokichi ^a   Soeda, Fumio ^a   Shirasaki, Tetsuya ^a   Takahama, Kazuo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antidepressant like action; Antitussives; Forced swimming test; G protein coupled inwardly rectifying potassium channel; Microdialysis method; Monoamine

Indexed keywords

ANTIDEPRESSANT AGENT; ANTITUSSIVE AGENT; BRAIN MONOAMINE; CARAMIPHEN; CLOPERASTINE; CORTICOTROPIN; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; NEUROTRANSMITTER; TIPEPIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG INHIBITION; FORCED SWIMMING TEST; HYPERACTIVITY; IMMOBILIZATION; LOCOMOTION; MALE; NONHUMAN; OLFACTORY BULBECTOMY; RAT; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; BRAIN; CYCLOPENTANES; DISEASE MODELS, ANIMAL; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; MALE; PIPERIDINES; RATS; RATS, WISTAR;

EID: 77951970592     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.699     Document Type: Review

References (46)

1. Inoue T., Koyama T., Seishin Igaku, 39, 6-14 (1997).
2. Inoue T., Koyama T., Rinshou Seishin Igaku, 26, 1603-1607 (1997).
3. Thase M. E., Rush A. J., "Treatment-Resistant Depression, Psychopharmacology: The Fourth Generation of progress," eds. by Bloom F. E., Kupfer D. J., Raven Press, New York, 1995, pp. 1081-1097.
4. White K., Wykoff W., Tynes L. L., Schneider L., Zemansky M., Psychiatr. J. Univ. Ottawa, 15, 156-158 (1990).
5. Lopez-Ibor J., Guelfi J. D., Pletan Y., Tornoux A., Prost J. F., Int. Clin. Psychopharmacol., 11(Suppl. 4), 41-46 (1996).
6. Nemoff C. B., Entsuah R., Willard L. B., Demitrack M. A., Thase M. E., Biol. Psychiatry, 63, 424-434 (2003).
7. Sitland-Marken P. A., Wells B. G., Froemming J. H., Chu C. C., Brown C. S., J. Clin. Psychiatry, 51, 68-82 (1990).
8. Cassano P., Lattanzi L., Soldani F., Navari S., Battistini G., Gemignani A., Battista G., Depress Anxiety, 20, 131-138 (2004).
9. Higuchi H., Kamata M., Sugawara Y., Yoshida K., Clin. Neuropharmacol., 28, 191-192 (2005).
10. Kasahara Y., Seishinka Chiryougaku, 17, 79-84 (2002).
11. Cho Y., Prog. Med., 25, 759-765 (2005).
12. Nemoff C. B., Kamijima K., Inoue T., Hamamura T., Watanabe K., Rinshou Seishin Yakuri, 8, 2119-2139 (2005).
13. Kuwano K., Ishibashi H., Takahama K., Jpn. J. Pharmacol., 82(Suppl. 1), P-112 (2000).
14. Takahama K., Shirasaki T., Soeda F., "Central Mechanisms III: Neuronal Mechanisms of Action of Centrally Acting Antitussives Using Electrophysiological and Neurochemical Study Approaches, Pharmacology and Therapeutics of Cough, Handbook of Experimental Pharmacology Vol. 187," eds. by Chung K. F., Widdicombe J., Springer-Verlag, Berlin, 2009, pp. 219-240.
15. North R. A., Br. J. Phamacol., 98, 13-28 (1989).
16. Ikeda K., Kobayashi T., Ichikawa T., Usui H., Kumanishi T., Biochem. Biophys. Res. Commun., 208, 302-308 (1995).
17. Ikeda K., Kobayashi T., Ichikawa T., Usui H., Abe S., Kumanishi T., Ann. N.Y. Acad. Sci., 801, 95-109 (1996).
18. Ikeda K., Kobayashi K., Kobayashi T., Ichikawa T., Kumanishi T., Kishida H., Yano R., Manabe T., Mol. Brain Res., 45, 117-126 (1997).
19. Yamamoto G., Soeda F., Shirasaki T., Takahama K., Can. J. Physiol. Pharmacol., 87, 893-899 (2009).
20. Fujieda Y., Soeda F., Shirasaki T., Takahama K., J. Phamacol. Sci., 100(Suppl. 1), 238P (2006).
21. Hirakawa E., Soeda F., Shirasaki T., Takahama K., Acta Pharmacol. Sin., 27(Suppl. 1), 103-104 (2006).
22. Porsolt R. D., Pichon M. L., Jalfre M., Nature, 266, 730-732 (1977).
23. Detke M. J., Rickels M., Lucki I., Psychopharmacology, 121, 66-72 (1995).
24. Hemby S. E., Lucki I., Gatto G., Singh A., Thonley C., Matasi J., Kong N., Simith J. E., Davies H. M. L., Dworkin S. I., J. Pharmacol. Exp. Ther., 282, 727-733 (1997).
25. Kawaura K., Ogata Y., Inoue M., Honda S., Soeda F., Shirasaki T., Takahama K., Behav. Brain Res., 205, 315-318 (2009).
26. Ráenáeric J. P., Lucki I., Psychopharmacology, 136, 190-197 (1998).
27. Kitada Y., Miyauchi T., Satoh A., Satoh S., Eur. J. Phamacol., 72, 145-152 (1981).
28. Kelly J. P., Wrynn A. S., Leonard B. E., Pharmacol. Ther.,74, 299-316 (1997).
29. Song C., Leonard B. E., Neurosci. Biobehav. Rev., 29, 627-647 (2005).
30. Kitamura Y., Araki H., Gomita Y., Pharmacol. Biochem. Behav., 71, 63-69 (2002).
31. Kitamura Y., Gomita Y., Jpn. J. Neuropsychopharmacol., 28, 93-100 (2008).
32. Linnéer L., Endersz H., Ohman D., Bengtsson F., Schalling M., Svensson T. H., J. Pharmacol. Exp. Ther., 297, 540-546 (2001).
33. Ichikawa J., Meltzer H. Y., Eur. J. Pharmacol., 281, 255-261 (1995).
34. Muneoka K., Shirayama Y., Takigawa M., Shioda S., Neurochem. Res., 34, 542-555 (2009).
35. Tanda G., Carboni E., Frau R., Di Chihara G., Psychopharmacology, 115, 285-288 (1994).
36. Li S. X., Perry K. W., Wong D. T., Neuropharmacology, 42, 181-190 (2002).
37. Nomikos G. C., Zis A. P., Damsma G., Fibiger H. C., Neuropsychopharmacology, 4, 65-69 (1991).
38. Nomikos G. C, Zis A. P., Damsma G., Fibiger H. C., Psychopharmacology, 105, 230-238 (1991).
39. Yoshida K., Higuchi H., Kamata M., Yoshimoto M., Shimizu T., Hishikawa Y., Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 21, 707-715 (1997).
40. Yoshida K., Higuchi H., Kamata M., Yoshimoto M., Shimizu T., Hishikawa Y., Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 22, 435-444 (1998).
41. Nomikos G. C., Damsma G., Wenkstern D., Fibiger H. C., Neuropsychopharmacology, 2, 273-279 (1989).
42. Segal D. S., Kuczenski R., Okuda C., Pharmacol. Biochem. Behav., 42, 421-429 (1992).
43. Ferigolo M., Barros H. M. T., Marquardt A. R., Tannhauser M., Pharmacol. Biochem. Behav., 60, 431-437 (1998).
44. Chaki S., Yoshikawa R., Hirota S., Shimazaki T., Maeda M., Kawashima N., Yoshimizu T., Yasuhara A., Sakagami K., Okuyama S., Nakanishi S., Nakazato A., Neuropharmacology, 46, 457-467 (2004).
45. Porsolt R. D., Anton G., Blavet N., JalfreM., Eur. J. Pharmacol., 47, 379-391 (1978).
46. Egawa T., Ichimaru Y., Imanishi T., Sawa A., Jpn. J. Pharmacol., 68, 71-75 (1995).